Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-002623

KERYX BIOPHARMACEUTICALS INC · KERX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Ron Bentsur
Officer — Chief Executive Officer · Director
Period of report
Jan 4, 2015
Accepted (ET)
Jan 6, 2015 · 8:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001114220

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jan 4, 2015A67,375$0.00A784,375D
Common StockF3,F2Jan 5, 2015S5,574$13.79D778,801D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F4$14.34Jan 4, 2015A134,750AJan 4, 2016Jan 4, 2025Common Stock134,750134,750D

Explanation of responses